GHDX

Genomic Health, Inc. News Headlines

$28.08
*  
0.05
0.18%
Get GHDX Alerts
*Delayed - data as of Aug. 21, 2014  -  Find a broker to begin trading GHDX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GHDX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Genomic Health, Inc. Enters Oversold Territory - Tale of the Tape
9/12/2012 11:19:01 AM - Zacks.com

Cepheid Remains Neutral - Analyst Blog
8/22/2012 2:32:51 PM - Zacks.com

Agilent Wins Patent in US - Analyst Blog
8/21/2012 3:33:39 PM - Zacks.com

Genomic Health Back to Neutral - Analyst Blog
8/20/2012 7:22:01 PM - Zacks.com

Genomic Health Targets Middle East - Analyst Blog
8/14/2012 4:15:01 PM - Zacks.com

Genomic Health Beats on EPS - Analyst Blog
8/9/2012 10:15:01 AM - Zacks.com

CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares
7/13/2012 12:46:30 PM - GuruFocus

Genomic Health to Outperform - Analyst Blog
7/6/2012 3:30:01 PM - Zacks.com

Cepheid Expands European Portfolio - Analyst Blog
5/29/2012 3:30:01 PM - Zacks.com

FDA Nod for Cepheid's Infinity-80 - Analyst Blog
5/25/2012 10:44:31 AM - Zacks.com

Myriad in Research Partnership - Analyst Blog
5/22/2012 3:30:01 PM - Zacks.com

Genomic Health Stays Neutral - Analyst Blog
5/21/2012 3:39:05 PM - Zacks.com

Myriad Reiterated Neutral - Analyst Blog
5/18/2012 2:40:41 PM - Zacks.com

Cepheid Back to Neutral - Analyst Blog
5/14/2012 3:06:48 PM - Zacks.com

Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter
5/10/2012 5:42:02 PM - International Business Times

Genomic Health Beats Estimates - Analyst Blog
5/3/2012 12:49:17 PM - Zacks.com

Myriad Beats, Raises Guidance - Analyst Blog
5/2/2012 3:45:01 PM - Zacks.com

Insiders are Spending MILLIONS on These 4 Small-Cap Stocks
4/10/2012 11:30:00 AM - Andy Obermueller

Cepheid Upgraded to Outperform - Analyst Blog
4/9/2012 3:30:01 PM - Zacks.com

Positive Data from Genomic Health - Analyst Blog
3/22/2012 3:21:50 PM - Zacks.com

Statins, Genomics, Patents, And Speculation
3/6/2012 1:11:00 PM - Seeking Alpha

Market's Reaction To M&A Possibilities In Sequencing Companies
3/6/2012 11:06:00 AM - Seeking Alpha

Myriad: Prolaris a Useful Test - Analyst Blog
2/28/2012 6:00:01 PM - Zacks.com

4 Stocks With Heavy Insider Buying
2/24/2012 8:34:00 AM - Seeking Alpha

Reiterating Genomic at Neutral - Analyst Blog
2/15/2012 3:45:01 PM - Zacks.com